Borosil Renewables (BORORENEW) Q1 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 25/26 earnings summary
18 Nov, 2025Executive summary
Standalone Q1 FY26 sales reached INR 332.26 crores, up 37% year-over-year, driven by higher selling prices and robust domestic demand.
EBITDA surged 211% year-over-year to INR 92.53 crores, with margins improving to 27.8% due to price increases and anti-dumping duties.
A one-time provision of INR 325.91 crores was made for the German subsidiary's insolvency, removing future drag on consolidated results.
Strategic exit from European operations via insolvency of German subsidiary, with focus realigned to Indian market and capacity expansion.
Consolidated Q1 FY26 net loss was Rs. 20,348.68 lakhs, significantly impacted by exceptional items related to subsidiary insolvency.
Financial highlights
Standalone sales: INR 332.26 crores (Q1 FY26) vs INR 241.82 crores (Q1 FY25); Q1 FY26 revenue up 37.4% year-over-year.
EBITDA: INR 92.53 crores (27.8% margin), up from INR 29.71 crores (Q1 FY25); exceptional item: INR 325.91 crores provision for German subsidiary.
Exports: INR 35.67 crores, 10.7% of turnover, up from 5.8% in the previous quarter.
Basic and diluted EPS (after exceptional items) for the quarter were Rs. (12.56) consolidated and Rs. (20.54) standalone.
Consolidated total expenses for Q1 FY26 were Rs. 31,727.96 lakhs, down from Rs. 40,386.97 lakhs in the previous quarter.
Outlook and guidance
Expectation of further improvement in sales and EBITDA for FY26, supported by strong domestic demand and stable prices.
EBITDA margin guidance of 28-30% for the coming quarters, with potential for a couple of percentage points improvement.
Volume growth of 6-8% expected for FY26; capacity utilization at 95%.
New 600 TPD capacity to be fully stabilized by March 2027; expansion plan to be commissioned by Dec 2026.
No explicit forward-looking guidance for the German subsidiary due to ongoing insolvency proceedings.
Latest events from Borosil Renewables
- Record sales, strong margins, and expansion plans offset by European subsidiary insolvencies.BORORENEW
Q3 25/263 Feb 2026 - Sequential margin gains in Q1 FY25, but losses continue amid export and cost pressures.BORORENEW
Q1 24/251 Feb 2026 - Q2 margins and profit improved, but overseas losses and regulatory delays affect expansion.BORORENEW
Q2 24/2515 Jan 2026 - Margins and profits fell on dumping and weak demand, but expansion and duties support recovery.BORORENEW
Q3 24/2529 Dec 2025 - Revenue and margin growth in India offset European losses; expansion and capital raise underway.BORORENEW
Q4 24/2520 Nov 2025 - Record margins and sales in Q2, but European subsidiary losses offset consolidated gains.BORORENEW
Q2 25/2612 Nov 2025